Abstract
Plasma Neurofilament Heavy Chain Levels correlate with disease severity and progression on multiple clinical outcomes in Amyotrophic Lateral Sclerosis (ALS) (S3.004)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have